Antigen-specific targeting and elimination of EBV-transformed B cells by allergen toxins.

  • Michael Stöcker
  • Torsten Klockenbring
  • Michael Huhn
  • Thomas Nachreiner
  • Daniel Wicklein
  • Arnd Petersen
  • Ralf Bauer
  • Roland Goerlich
  • Rainer Fischer
  • Stefan Barth

Abstract

With the exception of antigen-specific immunotherapy, current treatments for atopic diseases provide only symptomatic relief. Because of the increasing incidence of such diseases, the development of novel strategies and concepts for the treatment of allergies is urgently needed.

Bibliographical data

Original languageEnglish
Article number4
ISSN0091-6749
Publication statusPublished - 2005
pubmed 16210069